Heska Corporation

Company Details:

Company Symbol: HSKA
Sector: Medical Laboratories and Research
Company Rating:
URL: http://www.heska.com

Related Research

  • 08/01/17 Update HSKA ($109.54, Neutral; $96.50 PT): Solid Q2, but Beats on Revenue Shift; ’17 Guidance Reaffirmed; Strong Veterinary Market Expectations, Market Share Gains, and M&A Provide Long-Term Growth Platform for Heska
  • 08/01/17 Morning Note B. Riley AM Note: CAMT, BLKB, DCO, GRPN, HSKA, IVAC, NSIT, RLH, ROG, RTEC, SIMO, TIVO, XOXO; Focus List Update (BV, CARB, DHX.B, KTOS, LITE, MRVL, OOMA, PRMW, TRUE), Optical Components (ACIA, EMKR, INFN, NPTN, OCLR)
  • 07/26/17 Morning Note B. Riley AM Note: AKAM, AVGO, CAMP, CTG, DLB, HSKA, IIVI (downgrade), KEM, LLNW, MRVL, REIS, TXN
  • 07/26/17 Update HSKA ($103.31, Neutral; $85.00 PT): Q2 ’17 Earnings Preview: Expect In Line Quarter; Growth This Year Expected to be Somewhat Muted by Shift to Subscription Model for Imaging Business
  • 05/03/17 Update HSKA ($94.58, Neutral; $85.00 PT): Reports Mixed Q1 ’17; Maintaining Neutral Rating, but Raising Price Target from $81.00 to $85.00
  • 05/03/17 Morning Note B. Riley AM Note: AKAM, AMAT, ARC, AVGO, BLKB (downgrade), CARB, CSOD, DXCM, GDDY, GPX, GUID, HSKA, IIVI, INTC, IPHI, KLAC, LOV, LRCX, MBUU, MCFT, OCLR, SCVL, SQNS, SWKS, TNAV, TREC, TXN, VIAV
  • 04/28/17 Update HSKA ($105.22, Neutral; $83.00 PT): Expect Q1 ’17 Report In Line with Consensus; Remain Neutral on Valuation
  • 04/28/17 Morning Note B. Riley AM Note: BC, BRKS, COHU, COLM, CSGP (transition), DSW, GOOGL, GPX, HSKA, HZO, IDCC, INTC, KLAC, MCS, MPX, PCMI, PRMW, ROG, SIMO, SWKS, TNAV, TNDM, TYL, UAA, VRS (initiation); Optical Components (IIVI, IPHI, OCLR)
  • 03/01/17 Morning Note B. Riley AM Note: ACLS, AMC, BV, DXCM, GPX, HSKA, LIOX (discontinuation), MCHP, NAME, OOMA, PRGX, RLH, SHOO, XOXO
  • 03/01/17 Update HSKA ($92.74, Neutral; $83.00 PT): Strong Finish to ’16 As Q4 Posts Revenue and EPS Beat; Will Acquire Remaining Minority Stake in Heska Imaging; Raising Estimates and Price Target from $70.50 to $83.00
  • 02/23/17 Morning Note B. Riley AM Note: AXTI, BV, DMRC, DORM, GPX, HSKA, OSIS, WWW
  • 02/23/17 Update HSKA ($82.22, Neutral; $70.50 PT): Q4 ’16 Earnings Preview: Expect Results In Line With or Better and Solid Finish to ‘16; Introducing ’18 Estimates and Increasing Price Target from $55.50 to $70.50
  • 11/03/16 Update HSKA ($56.13, Neutral; $55.50 PT): Reports Q3 ’16 Revenue and EPS Beat; Management Raises ’16 Guidance; Raising Estimates and Price Target from $53.00 to $55.50
  • 11/03/16 Morning Note B. Riley AM Note: ACLS, AMRK, ARC, ARTX, AVGO, BCOV, BLKB, CBR, CLRO, DMRC, EXAR, FLWS, GDDY, HDSN, HSKA, III, IL, JAKK, KE, KTOS, MRVL, NCMI, NMRX, ROG, RUBI, SKX (downgrade), TACT, TST, VIVE (initiation), WEYS, XOXO, YELP, ZUMZ
  • 11/02/16 Morning Note B. Riley AM Note: ACLS, BLKB, CALD, CNK, DHX, DXCM, ELNK, GPX, HSKA, HZO, IPHI, IVAC, KEM, KTCC, KW, MBUU, OCLR, PRMW, RELY, RLH, RNWK, SANM, SHOO, TNAV, TNDM, TST, UEIC, VIAV
  • 10/28/16 Morning Note B. Riley AM Note: AMAT, AVGO, BC, CL, COLM, COHU, CSGP, DECK, DHX, FLEX, FORM, GOOGL, HSKA, IDCC, KTOS, LITE, MCS, NLS, NTCT, OCLR, OSIS, PCTI, PFSW, PLXS, PRGX, PRMW, RGC, SIMO, SPCB, SRI, SQNS, TNAV, TST, TUES, TYL, VVI; The Weiser Consumer
  • 10/28/16 Update HSKA ($47.72, Neutral; $53.00 PT): Q3 ’16 Earnings Preview: Expect Results In Line With Or Better Than Consensus; Remain Neutral On Valuation With $53.00 Price Target
  • 09/21/16 Update HSKA ($55.68, Neutral; $53.00 PT): Strong Stock Performance Moves Us to Sideline For Now; Continue to be Excited About Growth Trajectory, but Downgrading from Buy to Neutral on Valuation
  • 09/21/16 Morning Note B. Riley AM Note: AVGO, DTSI (downgrade), FINL, HSKA (downgrade), INTC, NAME, P, SSI, SWKS
  • 08/04/16 Update HSKA ($48.61, Buy; $52.50 PT): Another Solid Quarter and Increase to ’16 Guidance; R&D Spending Shifting to ’17; Raising Estimates and Price Target
  • 08/04/16 Morning Note B. Riley AM Note: ARTX, AVGO, CLX, CNK (upgrade), CROX, DWA, ELNK, EXAR, GDDY, HSKA, IL, KE, KLIC, NCMI, PG, RDNT, RNWK, ROG, SWKS, TROX, UEIC, WEYS, ZUMZ
  • 08/01/16 Morning Note B. Riley AM Note: ARC, COLM, DCO, DTSI, HDSN, HSKA, IDSY, IL, LGF, NMRX, NWL, REIS, SHOO (downgrade), TNAV, TROX, WEYS (downgrade); Semiconductors (EXAR, ON, MCHP), Semi. Cap. Equipment (ACLS, FORM, KLIC), Software (BLKB, CALD, CSOD, GUID)
  • 08/01/16 Update HSKA ($42.55, Buy; $42.50 PT): Q2 ’16 Earnings Preview: Expect In Line Quarter, Guidance Intact; Completes Cuattro International Acquisition
  • 05/04/16 Morning Note B. Riley AM Note: ARC, BEBE, CALD, CBR, CNK, COTY, ELNK, HSKA, IL, MRVL, NTRI, OCLR, PRMW, ROG, RUBI, SPA, TNAV, TREC, VIAV, WWW; Focus List Update (ABTL, BV, CHKE, DKS, IMAX, ISIL, KTOS, LITE, MCFT, NTRI, TACT, TNAV, VVI)
  • 05/04/16 Update HSKA ($35.86, Buy; $42.50 PT): Delivers Solid Q1 ’16 Results Revenue and EPS Beat on Better Than Expected Second Half of Quarter; Raises 2016 Outlook
  • 04/29/16 Morning Note B. Riley AM Note: BC, BCOV, BHE, BLKB, BRKS, CL, CLX, COHU, COLM, COTY, CSGP, EL, ELNK, FLEX, GPX, GRPN, HSKA, IDCC, IPHI, LGF, MCS, NPTN, OUTR, P, PCMI, PRGX, RGC, ROG, SIMO, SQNS, SWKS, TNAV, TYL, VVI, WMAR, WWW; Internet (ABTL, GDDY, PCOM, RUBI, TRUE, WEB, XOXO, YELP)
  • 04/28/16 Update HSKA ($29.58, Buy; $41.50 PT): Q1 ’16 Earnings Preview: Expect In Line Results; Update on Regulatory Progress and Cuattro International Transaction
  • 03/07/16 Morning Note B. Riley AM Note: AKAM, HSKA, IDCC, KTOS, PRMW, PSUN, SWKS, TST
  • 03/04/16 Update HSKA ($29.13, Buy; $41.50 PT): Delivers Solid Q4 Results; ’16 Outlook Confuses Leaving Stock Pullback With Strong ’17 Guidance Opportunity for Investors; Upgrading from Neutral to Buy
  • 03/01/16 Morning Note B. Riley AM Note: AMC, ATNY, CIEN, CKEC, CROX, HSKA, IDSY, RTEC, SWKS, TACT, WEB; March Focus List Update (ABTL, BV, CHKE, DKS, IMAX, ISIL, KTOS, LITE, MCFT, NTRI, TACT, TNAV, VVI)
  • 03/01/16 Update HSKA ($32.56, Neutral; $33.25 PT): Expect In Line Quarter and Update on Closing of Cuattro International Acquisition
  • 11/12/15 Morning Note B. Riley AM Note: FNSR, HSKA, JCP, MAMS, PFSW
  • 11/12/15 Update HSKA ($34.46, Neutral; $33.25 PT): Reports Strong Q3 ‘15 Beat; Announces Acquisition of Cuattro International Set to Close in Early January
  • 11/09/15 Update HSKA ($32.50, Neutral; $31.00 PT): Earnings Preview: Expect Q3 ‘15 Results In Line with Consensus
  • 11/09/15 Morning Note B. Riley AM Note: AMAT, AMRK, ARTX, BOOT, CSOD, EVOL, FTD, GSM, HSKA, III, NTRI, RDEN, VSAT; November Focus List Update
  • 07/30/15 Morning Note Morning Notes: AMC, CALD, CLX, CSGP, DORM, DWA, EGHT, FORM, HSKA, IDSY, ISIL, LRCX, MCS, NTRI, PCMI, SKX, SLAB, SONS, TYPE, UNTD
  • 07/30/15 Update HSKA ($32.00, Neutral; $31.00 PT): Delivers Q1 EPS Beat; Higher Operating Income Growth Expectations for Year End
  • 03/06/15 Morning Note B. Riley & Co. Morning Notes: CKEC, CLRO, CVU, DMD, FNSR, HSKA, IDSY, KFX, KTOS, PFSW, REIS, TREC; Focus List Update (CHKE, CKEC, EMKR, GME, GUID, ISIL, KTOS, NTRI, PRMW, REMY, RUBI)
  • 03/06/15 Update HSKA ($22.85, Neutral; $22.00 PT): Reports In-Line Revenues, but Earnings Fall Short; Maintaining Neutral Rating and Raising PT to $22
  • 07/31/14 Update HSKA ($13.20, Neutral; $14.25 PT): Delivers Strong Q2 ‘14 Beat
  • 07/31/14 Morning Note B. Riley & Co. Morning Notes: AKAM, AMC, COHR, COHU, DORM, FORM, GME, HSKA, ISIL, LRCX, NEWP, ROVI, STMP, YELP
  • 05/09/14 Update HSKA ($11.17, Neutral; $12.75 PT) Reports Roughly In Line Q1; Raising PT from $12.25 to $12.75
  • 05/09/14 Morning Note B. Riley & Co. Morning Notes: BEBE, BRKS, CVU, DMD, HSKA, IPAR, KW, LIOX, MDRX, NVDA, PCOM, TROX, XOXO
  • 03/28/14 Update HSKA ($11.21, Neutral; $12.25 PT): Reports Strong Q4 Results and Announces Leadership Transition; Raising PT From $6.00 to $12.25
  • 03/28/14 Morning Note B. Riley & Co. Morning Notes: ARTX, CLX, CONN, GME, HSKA, ISSI, WTSL, WYY
  • 11/07/13 Morning Note B. Riley & Co. Morning Notes: AEO, CBS, DIS, HSKA, KTOS, KW, LAMR, PCOM, OUTR, TWX, ZUMZ
  • 11/07/13 Update HSKA ($5.95, Neutral; $6.00 PT): Delivers Revenue and EPS Ahead of Our Model; Turnaround Emerging but We Remain on the Sidelines for Now
  • 08/12/13 Morning Note B. Riley & Co. Morning Notes: Consumer Products (C, COTY, IPAR, OR-Paris, RDEN, REV, WMT), HSKA, IPAR, LGF, Media (BTN, CKEC, CIDM, CNK, DCIN, IMAX, MCS, NCMI, RLD, RGC), MPAA, MRGE, ZQK
  • 08/12/13 Update HSKA ($6.21, Neutral; $6.00 PT): Near-term Remains Challenging; Lowering Estimates and PT to $6.00 from $8.50; Maintain Neutral Rating
  • 05/16/13 Morning Note B. Riley & Co. Morning Notes: BCOV, HSKA, REIS, SKX, SMTC, SPWR, VIAB, VOXX, VSAT
  • 05/15/13 Update HSKA ($7.60, Neutral; $8.50 PT): Heska Imaging Provides Long Term Promise But Near Term Challenges Intensify; Reducing Estimates and Lowering PT to $8.50 from $9.50
  • 04/25/13 Morning Note B. Riley & Co. Morning Notes: ACW, AMZN, ANGI, BIRT, CAKE, CLRO, COHR, DAVE, GFN, HSKA, ISIL, LOV, LRCX, MTSN, PG, RLD, SKX, SLAB, STMP, SYMM, TUP
  • 04/24/13 Initiation of Coverage HSKA ($8.40, Neutral; $9.50 PT): Transitioning HSKA from Flash Research to Full Coverage with a Neutral Rating and a $9.50 PT
  • 02/26/13 Flash Report HSKA ($8.25, Flash Research): HSKA Acquires Cloud-Enabled Imaging Company to Reinvigorate Growth; Delivers First Shipment to Its New National Distributor
  • 11/15/12 Flash Report HSKA (Flash Research): Further escalation in competition weighs heavily on quarter; HSKA still pursuing attractive, long-term growth avenues
  • 11/15/12 Morning Note B. Riley & Co. Morning Notes: HOTT, HSKA, LOV, PPC, RLD
  • 08/13/12 Morning Note B Riley & Co. Morning Notes: AEO, BCOV, HSKA, MYGN, PPC, PSUN, Q2 '12 Earnings Preview, SRI, SSI
  • 08/12/12 Flash Report HSKA (Flash Research): Growth runway extended but still promising; pipeline stumbles coinciding with increased competitive pressures and slack demand
  • 08/07/12 Morning Note B. Riley & Co. Morning Notes: BANC, CMLS, EMKR, EVOL, GHDX, HSKA, LIOX, PCOM, PPC, SABA, TTGT, VTSS, XOXO
  • 05/14/12 Morning Note B. Riley & Co. Morning Notes: BC, CACH, GRPN, HSKA, OPNT, RLD, SPA, Industry Update: Exhibitors and Related Technologies, Q1 '12 Earnings Preview
  • 05/13/12 Flash Report HSKA (N/R): Mix shift expands margins and leads to big EPS beat on slightly better than expected revenue; improving industry fundamentals and new product launches to drive sizable growth
  • 05/07/12 Morning Note B. Riley & Co. Morning Notes: DRL, EVOL, Exhibitors and Related Technologies, GRPN, HSKA, LIOX, TWO
  • 04/23/12 Morning Note B. Riley & Co. Morning Notes: ACW, BC, BPOP, CSTR, CYN, DRCO, GBCI, HSKA, MPAA, NFLX, PPC, PVSW, SIX, STMP, VECO, Industry Update: Exhibitors and Related Technologies
  • 04/22/12 Update HSKA (N/R): Competitor IDXX to loosen stranglehold on national distributors, reports positive industry datapoints
  • 04/22/12 Flash Report HSKA (N/R): Competitor IDXX to loosen stranglehold on national distributors, reports positive industry datapoints
  • 03/13/12 Flash Report HSKA (N/R): HSKA enters retail channel with generic heartworm product, the first of four new products set to drive revenue and margin expansion
  • 02/28/12 Morning Note B. Riley & Co. Morning Notes: ABTL, ACW, CAMP, FNSR, GPX, HSKA, PCOM, PCTI, SNAK
  • 02/27/12 Flash Report HSKA (N/R): EPS expected to rise by 67% in 2012 on new product introductions; attractive valuation, dividend yield, and a takeout candidate to boot